Polaris Market Research recently launched the latest update on US Biomarkers Market Size, Share, Trends, & Industry Analysis By Type, (Safety US Biomarkers, Efficacy US Biomarkers, and Validation US Biomarkers), By Research Area, By Technology, By Disease Indication, By Application, and By Country – Market Forecast, 2025-2034 that gives an extensive outlook of the market, analyzing facts, current growth factors, future trends, historical data, attentive opinions, and industry-validated data forecasts.
US Biomarkers Market size and share is currently valued at USD 25.92 billion in 2024 and is anticipated to generate an estimated revenue of USD 106.03 Billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 15.16% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2025 – 2034
𝐆𝐞𝐭 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
http://www.polarismarketresearch.com/industr…for-sample
The U.S. biomarkers market is expanding due to strong investment in personalized medicine, diagnostics, and targeted therapy development. Oncology remains the largest application segment due to extensive use in patient stratification and treatment monitoring.
Rapid advances in molecular testing technologies support growth in genomic, proteomic, and metabolomic biomarkers. Government and private research funding continues to increase to accelerate clinical adoption.
Pharmaceutical companies rely heavily on biomarkers in drug discovery to improve trial outcomes and reduce development timelines. Hospitals and laboratories are investing in advanced testing infrastructure for early disease detection.
Regulatory approval pathways are becoming more supportive of precision diagnostics. AI-powered analytics enhance interpretation of biomarker datasets.
Rising demand for non-invasive testing also supports market evolution.
US Biomarkers Market Key Growth Drivers
* Growth of precision medicine and tailored treatment approaches
* Increasing prevalence of chronic and genetic disorders
* Technological advancements enabling fast biomarker discovery
* Expanding adoption in clinical trials to improve patient outcomes
* High R&D investment in biotechnology and pharma sectors
* Improved diagnostics infrastructure and healthcare spending
Key Player Analysis:
The report provides a detailed analysis of the US Biomarkerss Market key players encompassing their product and service market segmentation, revenue, share, product portfolios, capabilities, market positions, geographic footprints, and entry strategies. The report helps readers comprehend the unique positions that these businesses hold in the developing worldwide market.
Sales figures, gross margin analysis, profit margins, and price patterns concerning each firm have been inculcated in the report.
𝐌𝐚𝐣𝐨𝐫 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:
* Abbott Laboratories
* Agilent Technologies, Inc.
* Bio-Rad Laboratories, Inc.
* Charles River Laboratories International, Inc.
* Exact Sciences Corporation
* Guardant Health, Inc.
* Hologic, Inc.
* Illumina, Inc.
* Johnson & Johnson Services, Inc.
* Laboratory Corporation of America Holdings
* Meso Scale Diagnostics, LLC
* PerkinElmer, Inc. (Revvity, Inc.)
* Quest Diagnostics Incorporated
* Thermo Fisher Scientific, Inc.
𝐕𝐢𝐬𝐢𝐭 𝐎𝐮𝐫 𝐖𝐞𝐛𝐬𝐢𝐭𝐞 𝐟𝐨𝐫 𝐌𝐨𝐫𝐞 𝐃𝐞𝐭𝐚𝐢𝐥𝐬:
http://www.polarismarketresearch.com/industr…ers-market
Key Findings from The Report:
* The report illustrates an analysis showing product/service consumption in a region along with elements influencing the US Biomarkerss Market in each area.
* Report outlines the global potential and risks that vendors must deal with.
* The analysis identifies the regions and industries with the most potential for growth.
* A competitive market with notable firm rankings, the introduction of new products, corporate growth, and acquisitions is incorporated in the report.
* The research includes business overviews, corporate insights, product benchmarking, and SWOT analysis for each important market participant.
* The report takes into account current developments, motivating factors, obstacles, and geographical constraints that are present in developed regions.
Segmentation Overview:
US Biomarkers Market segmentation analysis is done on the basis of types, applications, regions, and key players. The market’s key demographic, regional, and behavioral data are aimed at helping to determine the characteristics a firm should offer in order to meet the needs of the business.
Also, market maker information is used to categorize the study to better understand clients buying behavior and patterns for the consumer-based market. Our analysts ensure the report is segmented with accurate marketing & sales channels to recognize prospective industry size by revenue and volume.
U.S. biomarkers Market, Disease Indication Outlook (Revenue, USD Billion, 2020-2034)
* Safety US Biomarkers
* Efficacy US Biomarkers
* Validation US Biomarkers
U.S. biomarkers Market, Research Area Outlook (Revenue, USD Billion, 2020-2034)
* Genomics
* Proteomics
* Metabolomics
* Other Research Areas
U.S. biomarkers Market, Technology Outlook (Revenue, USD Billion, 2020-2034)
* Immunoassays
* Next-Generation Sequencing (NGS)
* Polymerase Chain Reaction (PCR)
* Mass Spectrometry
* Chromatography
* Other Technologies
U.S. biomarkers Market, Disease Indication Outlook (Revenue, USD Billion, 2020-2034)
* Cancer
* Infectious Disease
* Immunological Disorders
* Neurological Disorders
* Cardiovascular Disorders
* Other Disease Indications
U.S. biomarkers Market, Application Outlook (Revenue, USD Billion, 2020-2034)
* Clinical Diagnostics
* Drug Discovery & Development
* Personalized Medicine
* Clinical Research
* Other Application
𝐀𝐬𝐤 𝐀𝐧 𝐀𝐧𝐚𝐥𝐲𝐬𝐭 𝐅𝐨𝐫 𝐘𝐨𝐮𝐫 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐞𝐝 𝐒𝐚𝐦𝐩𝐥𝐞:
http://www.polarismarketresearch.com/industr…tomization
Key Questions Answered in Report
Q – What is the size of the market for a specific product or service, and what are the primary drivers and challenges?
Ans – USD 25.92 billion (2024) → USD 106.03 billion (2034), 15.16% CAGR; Drivers: Rising cancer incidence (2,041,910 new cases 2025), US healthcare spending (USD 4.9 trillion 2023), Precision Medicine Initiative, FDA Fit-for-Purpose Initiative, NIH funding; Challenges: High validation needs, development costs, reimbursement uncertainty.
Q – What are the top players in a specific industry or market, as well as their shares, competitive tactics, and strengths and weaknesses?
Ans – Key players include Abbott Laboratories, Agilent Technologies, Bio-Rad, Charles River, Exact Sciences, Guardant Health, Hologic, Illumina, Johnson & Johnson, LabCorp, Quest Diagnostics, Thermo Fisher; Tactics: AI-powered analytics, liquid biopsy development, companion diagnostics, disease-specific panels, academic partnerships, digital ecosystem integration.
Q – What are the present patterns and future growth prospects for a specific sector or market, and what causes are driving these trends?
Ans – Multi-omics platforms, blood-based assays, imaging biomarkers, population genomics, real-time monitoring; Prospects: Neurological disorders fastest CAGR (7M to 13M Alzheimer’s by 2050), personalized medicine strong growth, NGS segment rapid expansion, proteomics fastest rise.
Q – What are the opportunities and challenges that businesses in a specific industry face?
Ans – Opportunities: Tracking cell/gene therapies, minimal residual disease monitoring, preventive screening uptake, pharmacogenomics expansion; Challenges: Extended clinical validation timelines, data standardization issues, complex regulatory pathways, variability across laboratories.
Q – What are the most recent industry developments that can be used to produce new revenue streams?
Ans – Columbia University CIMBID center launch (June 2025), University of Houston USD 3 million CPRIT-funded cancer biomarker facility (May 2025), Bio-Techne AmplideX Nanopore Carrier Plus Kit release (March 2025), Perspectum FDA Drug Development Tool grant USD 250,000 (November 2024).
News From
Polaris Market Research &…
Category: Industry Reports & Market Analysis Profile: Polaris Market Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight and market intelligence to our customers across various industries. We at Polaris are obliged to serve our client base across the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, ch …
This email address is being protected from spambots. You need JavaScript enabled to view it.
